# Autologous suraL nervE Grafting to the Substantia nigrA in Patients With Synuclienopathies

> **NCT06683365** · PHASE1 · RECRUITING · sponsor: **Craig van Horne, MD, PhD** · enrollment: 7 (estimated)

## Conditions studied

- Multiple System Atrophy
- Parkinsons Disease

## Interventions

- **PROCEDURE:** Sural Nerve Graft to the Substantia Nigra
- **PROCEDURE:** Sham surgery

## Key facts

- **NCT ID:** NCT06683365
- **Lead sponsor:** Craig van Horne, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-25
- **Primary completion:** 2028-12-02
- **Final completion:** 2030-12-02
- **Target enrollment:** 7 (ESTIMATED)
- **Last updated:** 2026-04-01

## Collaborators

- University of Kentucky CCTS
- National Center for Advancing Translational Sciences (NCATS)

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06683365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06683365, "Autologous suraL nervE Grafting to the Substantia nigrA in Patients With Synuclienopathies". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06683365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*